Excited to partner with Neogia to bring new tech to humans via our early phase unit dcri.org/earlyphase @DCRINews @DukeMedSchool
Following the announcement of the nominees, Neogia and its partners Duke Clinical Research Institute and Analog Devices are participating today, in the ceremony of the Galien #Medstartup USA Award at #NewYork #USA , for the solution Motio HW.
#PrixGalien #NeogiaTech
Credit goes to all the staff at DEPRU for making this happen DCRI.org/earlyphase
DCRI begins early-stage clinical trial of #antimalarial drug. The new study -- sponsored by the NIAID and led by DCRI's @mickycwMD -- is testing an investigational drug called DM1157 bit.ly/2O5eaOb @NIAIDNews @NIH
Kudos to our outstanding and dedicated staff that is enrolling like crazy for Project Baseline DCRI.org/earlyphase @DCRINews xitter.cf/dukemedschool/status/1…
1-year mark for Project Baseline study. Ambitious effort to develop well-defined “baseline” of health, and rich data platform to better understand health & disease and transitions between them. Duke, Verily, Stanford Med, Google collaborate. @Duke_CTSI ow.ly/oVWd30kJcSL
Also think @Book_Harvest xitter.cf/pediatrictrials/status…
This Post is from an account that no longer exists. Learn more
This is such a powerful program - how do we increase the pipeline of underrepresented minority scientists if we don’t start early? So much talk about diversity inclusion and not enough action. STAR is action. @PediatricTrials @PedsDanny @DukeMedSchool @DCRINews xitter.cf/pediatrictrials/status…
This Post is from an account that no longer exists. Learn more
Neonatal studies are tough, but dedicated investigators and families together can do it - @US_FDA recognized the value and need - read last bullet @PediatricTrials @NICHD_NIH @EMA_News
Looking forward to expanding partnerships between @PediatricTrials and @KidsCANtrials xitter.cf/pediatrictrials/status…
This Post is from an account that no longer exists. Learn more
Grateful to be a part of this group of humans @PediatricTrials @PedsDanny talk about accelerating pediatric drug development with a fully established peds network @US_FDA @EMA_News @DukeMedSchool xitter.cf/dcrinews/status/100918…
DCRI’s Pediatric Trials Network (PTN) team has been awarded $96 million by @NICHD_NIH to design and lead #pediatric trials over the next eight years. bit.ly/2tiIdJd @PediatricTrials @PedsDanny @mickycwMD
Privileged to be @EMA_News discussing the future of antibiotic development in children with @US_FDA where @PediatricTrials recognized for moving the needle
Agree @califf001 heavy publication bias for phase 1 even outside of oncology DCRI.org/earlyphase @NEJM xitter.cf/califf001/status/10059…
Great review - incorporating maturation of PD endpoints will be key - we can tackle this @micyrn @PediatricTrials xitter.cf/micyrn/status/10011900…
Useful pharmacodynamic endpoints in children: selection, measurement, and next steps: rdcu.be/PrXJ
Implementing new tech in early phase research - ready to launch Hu.BITS at Duke: human biomarker discovery and tech eval study DCRI.org/earlyphase - new era, new signals of drug effect @DCRINews xitter.cf/dcrinews/status/999688…
Clinical Research Day, co-hosted by @DukeMedSchool @dukegme & DCRI, highlighted role of new technologies in bldg partnerships: "One of the most important drivers for advancing clinical research is the use of new technologies," said @texhern bit.ly/2LrAuAK
Such a need for these absorption studies - we can start with adults at DCRI.org/earlyphase and then move to children, pregnant women and older adults - not many people thinking about these risks xitter.cf/califf001/status/99928…
Lessons learned from pediatric trials can accelerate trials in pregnant women - such a need @PediatricTrials xitter.cf/micyrn/status/99894405…
Pregnant Women Need Inclusion in Research, Task Force Says medpagetoday.com/obgyn/pregn…
This is such a big deal for @PediatricTrials and partners such as @RCHMelbourne and @kids_research - easy to write in a tweet but a lot of effort to make it a reality - a step closer to a global peds clin trials network xitter.cf/pediatrictrials/status…
This Post is from an account that no longer exists. Learn more
Anybody wonder the potential toxicities of chronic chemical application of sunscreen in children? Skin cancer prevention benefit is clear - but are we overlooking potential side effects? Wonder what @califf001 thinks @PediatricTrials xitter.cf/pediatrictrials/status…
This Post is from an account that no longer exists. Learn more
Agree with @califf001 and @RossMcKinneyMD - substantial problem if folks have the illusion that phase 1 provides sufficient evidence for patient treatment - especially because at least half of the doses at this phase are subtherapeutic DCRI.org/earlyphase xitter.cf/califf001/status/99928…
Should we beta-test a ‘look up’ pilot to have some smartphone breaks @texhern ? xitter.cf/texhern/status/9972315…
Looking forward to exploring how these drugs might apply to pediatric migraine given known differences between adult and pediatric disease - good opportunity for @PediatricTrials xitter.cf/drdorird/status/997273…
So allofus = allofusAdults? @ericdishman @AllofUsResearch #dontleavekidsbehind xitter.cf/ericdishman/status/997…
This Post is from a suspended account. Learn more













